Zenas BioPharma Inc.

NASDAQ: ZBIO · Real-Time Price · USD
16.82
0.06 (0.36%)
At close: Aug 15, 2025, 3:59 PM
17.00
1.07%
After-hours: Aug 15, 2025, 05:40 PM EDT

Zenas BioPharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Net Income
-156.99M -37.12M -119.28M
Depreciation & Amortization
137K 113K 78K
Stock-Based Compensation
10.82M 3.5M 737K
Other Working Capital
13.69M -7.62M 6.88M
Other Non-Cash Items
925K 11.03M 44.85M
Deferred Income Tax
n/a n/a n/a
Change in Working Capital
25.43M -8.04M 7.97M
Operating Cash Flow
-119.67M -30.53M -65.65M
Capital Expenditures
-131K -17K -2.2M
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
-36.42M n/a n/a
Sales Maturities Of Investments
6M n/a n/a
Other Investing Acitivies
n/a n/a -2M
Investing Cash Flow
-30.55M -17K -2.2M
Debt Repayment
n/a 20M n/a
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a
Financial Cash Flow
412.96M 20.12M 59.39M
Net Cash Flow
262.89M -10.35M -8.5M
Free Cash Flow
-119.81M -30.55M -67.85M